Brevital Sodium

Brevital Sodium Uses, Dosage, Side Effects, Mechanism of Action, How Long Does it Take to Work? Brevital Sodium is a brand name. Its generic name is Methohexital.

Brevital Sodium Introduction

Brevital Sodium, also known as Brevital, is a fast-acting barbiturate that has sedative-hypnotic and general anaesthetic effects. It is used for general anaesthesia in cosmetic and dental surgery, and to induce deep sedation for short duration medical procedures. Brevital Sodium can also be used to prevent epileptic seizures.

Uses for Brevital Sodium

Brevital Sodium is used to induce general anaesthesia and deep sedation. It is used in cosmetic and dental surgery, and for short duration medical procedures such as bronchoscopy, endoscopy, and transrectal ultrasonography (TRUS). It is also used to prevent epileptic seizures.

Mechanism of Action

Brevital Sodium works by increasing the activity of the inhibitory neurotransmitter GABA (gamma-Aminobutyric acid). GABA is a neurotransmitter that reduces the activity of the nerve cells in the brain and spinal cord, and this leads to a decrease in neuronal activity. This results in a calming and sedative effect.

How long does it take to work?

Brevital Sodium has a rapid onset of action, usually within 30-60 seconds, and its effects last for 5-15 minutes or more depending on the dose.

Absorption

Brevital Sodium is rapidly absorbed after intravenous or intramuscular injection. It is also absorbed after oral administration.

Route of Elimination

Brevital Sodium is metabolized in the liver and eliminated primarily by the kidneys.

Dosage

The dose of Brevital Sodium for adults is 0.5 mg/kg IV or IM. Inject slowly over 10-15 seconds or slow IV infusion, up to 1mg/kg. The dose for children is 0.5-1 mg/kg IV. Brevital Sodium injection should not be given as a bolus injection.

Administration

Brevital Sodium can be administered via intravenous injection or infusion, intramuscular injection, and oral tablets.

Side Effects

Common side effects of Brevital Sodium include drowsiness, nausea and vomiting, dizziness, headache, restlessness, miosis (constriction of the pupils), and hypotension (low blood pressure). Rare or serious side effects may include respiratory depression, cardiac arrhythmia, and seizures.

Toxicity

High doses of Brevital Sodium may lead to respiratory depression, hypotension, coma and death. If Brevital Sodium is used in excessive doses, patients may experience central nervous system depression, respiratory depression, and cardiovascular collapse.

Precaution

Brevital Sodium should be used with caution in patients with a history of drug abuse, respiratory or cardiovascular diseases, and other relevant medical conditions. It should not be used in patients who have taken other sedative drugs in the past such as benzodiazepines or opioids as they may cause additive effects.

Interaction

Brevital Sodium may interact with other drugs, including narcotics, barbiturates, alcohol, antihistamines, and other central nervous system depressants. It should not be used in combination with these drugs as it can lead to additive effects.

Disease Interactions

Brevital Sodium should not be used in patients with a history of porphyria or aneurysm or in patients with severe pulmonary disease. It should also not be used in patients with severe hepatic impairment, as the drug is partly metabolized in the liver.

Drug Interactions

Brevital Sodium may interact with other drugs, including narcotics, barbiturates, alcohol, antihistamines, and other central nervous system depressants. It should not be used in combination with these drugs as it can lead to additive effects.

Food Interactions

Brevital Sodium should not be taken with alcohol or with other drugs that have sedative effects such as barbiturates, narcotics, or antihistamines.

Pregnancy Use

Brevital Sodium is not recommended for use in pregnant women as it can cause harm to the unborn baby. Animal studies have shown that Brevital Sodium can cause fetal harm and other risks. It should be used only if the potential benefit justifies the potential risk to the fetus.

Lactation Use

Brevital Sodium use is not recommended in nursing mothers as it may pass into the breast milk and cause harm to the infant. Nursing mothers should consult their doctor before using Brevital Sodium.

Acute Overdose

An acute overdose of Brevital Sodium can lead to respiratory depression, hypotension, cardiac arrhythmias, coma, and death. Treatment of overdose typically involves supportive care, such as intravenous fluids and oxygen, and administration of a benzodiazepine or narcotic antagonist.

Contraindication

Brevital Sodium is contraindicated in patients with porphyria, severe pulmonary disease, severe hepatic impairment, aneurysm, or an allergy to barbiturates.

Use Direction

Brevital Sodium should be used as directed by the doctor or healthcare professional who prescribed it. Follow all instructions carefully and do not use more than prescribed. Do not give Brevital Sodium to a child without a doctor’s prescription.

Storage Condition

Brevital Sodium should be stored at controlled room temperature, away from light and heat. Do not store in refrigerator or freezer. Keep the medication out of reach of children and pets.

Volume of Distribution

Brevital Sodium is widely distributed throughout the body, with an estimated volume of distribution of 0.4 – 0.6 L/kg.

Half Life

The half-life of Brevital Sodium is 15-30 minutes.

Clearance

Brevital Sodium is mainly metabolized in the liver, with an estimated clearance of 1.08 mL/min/kg.

Here you find in details version of Brevital Sodium

Some Frequently Asked Questions About Brevital Sodium

https://www.medicinesfaq.com/brand/brevital-sodium, http://classyfire.wishartlab.com/tax_nodes/C0000000, http://classyfire.wishartlab.com/tax_nodes/C0000002, http://classyfire.wishartlab.com/tax_nodes/C0001346, http://classyfire.wishartlab.com/tax_nodes/C0000075, http://classyfire.wishartlab.com/tax_nodes/C0000292, http://classyfire.wishartlab.com/tax_nodes/C0002023, http://classyfire.wishartlab.com/tax_nodes/C0002389, http://classyfire.wishartlab.com/tax_nodes/C0003033, http://classyfire.wishartlab.com/tax_nodes/C0004139, http://classyfire.wishartlab.com/tax_nodes/C0004557, http://classyfire.wishartlab.com/tax_nodes/C0000278, http://classyfire.wishartlab.com/tax_nodes/C0003940, http://classyfire.wishartlab.com/tax_nodes/C0004150, http://classyfire.wishartlab.com/tax_nodes/C0001831, https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:102216, http://www.hmdb.ca/metabolites/HMDB0014617, http://www.genome.jp/dbget-bin/www_bget?drug:D04985, http://www.genome.jp/dbget-bin/www_bget?cpd:C07844, https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=9034, https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=46507954, https://www.chemspider.com/Chemical-Structure.8683.html, https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=6847, https://www.ebi.ac.uk/chebi/searchId.do?chebiId=102216, https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL7413, http://bidd.nus.edu.sg/group/cjttd/ZFTTDDRUG.asp?ID=DAP000677, http://www.pharmgkb.org/drug/PA164784030, http://www.rxlist.com/cgi/generic3/methohexital.htm, https://www.drugs.com/cdi/methohexital.html, https://en.wikipedia.org/wiki/Methohexital,